Company Overview and News

Sri Lanka’s CIC buys specialty fertilizer firm for Rs.238Mn

2017-10-17 lankabusinessonline
Oct 17, 2017 (LBO) – Sri Lanka’s CIC Holdings, a subsidiary of CIC Holdings said it acquired a 70 percent stake in  Unipower (Pvt) Limited, a firm that specializes fertilizers.

Global Starch - Food & Beverage

2017-01-05 prnewswire
LONDON, Jan. 4, 2017 /PRNewswire/ -- This report analyzes the worldwide markets for Starch in Thousand Metric Tons by the following Product Segments: Dry Starch (Native Starch, Modified Starch, & Other Dry Starches), and Liquid Starch. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022.

CIC Holdings PLC headlines the World Economic Development Forum as a Silver sponsor

CIC Holdings PLC is proud to be the Silver Sponsor for the World Export Development Forum (WEDF), organized by the Sri Lanka Export Development Board (EDB) at the BMICH from 12th-13th October 2016. A leading blue chip company in Sri Lanka, CIC Holdings stepped forward to extend support to this globally significant conference which will witness the convergence of policy-makers and business leaders from around the globe.

CIC Introduces ‘PediaSure’ new package range to the Sri Lankan market at a special price

CIC Holdings, the sole agent for Abbott Nutrition for Sri Lanka announced the introduction of PediaSure, a world-renowned children’s nutrition supplement to the Sri Lankan market in a new packaging line, at a special price. Launched under the theme, ‘Designed for Value’, PediaSure new packaging line offers consumers value for money in 1kg and 400gram cartons. A host of distinguished invitees including the senior management and employees of CIC Holdings and senior South Asia representatives of Abbott Nutrition were present at the new packaging range launch which took place recently in Colombo.

CIC’s Cial appointed to distribute art & craft product range of Pidilite Industries Private Limited,India

Cial, a renowned brand owned by CIC Holdings PLC recently partnered with Pidilite Industries Limited India to distribute the Pidilite art & crafts product range through the CIAL stationery product distribution channel. Cial is one of the key stationery brands in Sri Lanka manufactured and marketed by CIC Holdings which manufactures a range of stationery products including it’s flagship brand Platignum.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

21h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

21h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...